M 745 (Benazepril hydrochloride and hydrochlorothiazide 20 mg / 12.5 mg)

Pill imprint M 745 has been identified as Benazepril hydrochloride and hydrochlorothiazide 20 mg / 12.5 mg.

Benazepril/hydrochlorothiazide is used in the treatment of high blood pressure and belongs to the drug class antihypertensive combinations. There is positive evidence of human fetal risk during pregnancy. Benazepril/hydrochlorothiazide 20 mg / 12.5 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for M 745 (Benazepril hydrochloride and hydrochlorothiazide 20 mg / 12.5 mg)

Benazepril hydrochloride and hydrochlorothiazide 20 mg / 12.5 mg M 745  Front
Benazepril hydrochloride and hydrochlorothiazide 20 mg / 12.5 mg M 745  Back
Benazepril hydrochloride and hydrochlorothiazide 20 mg / 12.5 mg M 745
Benazepril hydrochloride and hydrochlorothiazide
Imprint:
M 745
Strength:
20 mg / 12.5 mg
Color:
Beige
Size:
16.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Antihypertensive combinations
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-4745
Inactive Ingredients:
lactose anhydrous
ferrosoferric oxide
silicon dioxide
crospovidone
hypromelloses
polydextrose
polyethylene glycol
corn starch
stearic acid
magnesium silicate
titanium dioxide
triacetin
ferric oxide yellow
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
58016-0065 Southwood Pharmaceuticals Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web5)